Roflumilast Preparation Process Yield and Purity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current processes for preparing Roflumilast are inefficient and lack a stable, industrially scalable crystalline form, which affects its production yield and purity.

Innovation Solution

A novel process involving the reaction of 4-Difluoromethoxy-3-hydroxy benzaldehyde with a cyclopropylmethyl compound in the presence of an organic base, followed by oxidation and condensation with 4-amino-3,5 Dichloropyridine, to obtain Roflumilast, with optional purification in an organic solvent, resulting in a stable crystalline Form-I.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current processes for preparing Roflumilast are used, then the production can be maintained, but the yield and purity are insufficient

Engineering Contradiction:
ImproveyieldVSAvoidpurity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent optimizes reaction parameters including temperature ranges (0-50°C for alkylation, room temperature for condensation), solvent selection (dichloromethane, ethyl acetate, toluene), and stoichiometric ratios to simultaneously improve yield and purity of Roflumilast

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces intermediate purification steps using organic solvents to isolate and purify key intermediates (4-Difluoromethoxy-3-hydroxy benzaldehyde and 3-cyclopropylmethoxy-4-Difluoromethoxy benzaldehyde) before final condensation, thereby improving overall product purity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If current processes for preparing Roflumilast are used, then the production can be maintained, but the process lacks industrial scalability

Engineering Contradiction:
Improveindustrial scalabilityVSAvoidprocess stability
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent divides the synthesis into distinct modular stages: (a) alkylation of benzaldehyde, (b) oxidation to benzoic acid, and (c) condensation with 4-amino-3,5-dichloropyridine. Each stage uses optimized conditions and can be independently controlled, facilitating industrial scaling

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs continuous extraction and filtration steps between reaction stages to remove impurities and transfer intermediates efficiently, maintaining continuous production flow and improving overall process stability for industrial application

Inventive Principle:
Principle #20Continuity of useful action

3Stability of the object's composition

If Roflumilast is produced without a stable crystalline form, then the synthesis can be simplified, but the product stability is compromised

Engineering Contradiction:
Improvecrystalline stabilityVSAvoidcrystallization process
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent utilizes controlled crystallization from organic solvents to obtain stable crystalline Form-I of Roflumilast. The phase transition from solution to crystal is controlled by solvent selection and temperature management, ensuring product stability without excessive process complexity

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The patent optimizes crystallization parameters including solvent type (organic solvents), temperature profiles, and cooling rates to obtain stable crystalline Form-I with characteristic X-ray diffraction patterns, balancing product stability with process simplicity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process enhances the yield and purity of Roflumilast, providing a commercially feasible and stable crystalline form characterized by specific X-ray diffraction patterns and thermal stability, thus improving the production efficiency.

Implementation Method 1

reacting 4-Difluoromethoxy-3-hydroxy benzaldehyde of Formula II with a cyclopropylmethyl compound of Formula III in the presence of an organic base to obtain 3-cyclopropylmethoxy-4-Difluoromethoxy benzaldehyde of Formula IV

Methodology Applied
Scientific EffectNucleophilic substitution: Chemical Bonding

Implementation Method 2

oxidising the obtained aldehyde compound of Formula IV into 3-cyclopropylmethoxy-4-Difluoromethoxy benzoic acid of Formula V

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

converting 3-cyclopropylmethoxy-4-Difluoromethoxy benzoic acid of Formula V to its acid halide and condensing with 4-amino-3,5 Dichloropyridine in presence of base to obtain Roflumilast

Methodology Applied
Scientific EffectCondensation reaction: Chemical Bonding

Implementation Method 4

optionally purifying Roflumilast in an organic solvent to get pure Roflumilast

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 5

purification of Roflumilast in an organic solvent

Methodology Applied
Scientific EffectSolvation: Solvation

Data Source

PatentUS9145365B2Process for the preparation of Roflumilast
Publication Date: 2015.09.29 TIANISH LABORATORIES PTE LTD
  • US9145365B2 patent drawing
  • US9145365B2 patent drawing
  • US9145365B2 patent drawing

AI summary

The present invention relates to an improved process for the preparation of Roflumilast. The present invention also relates to crystalline Form-I of Roflumilast.